Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis

Published:2023-09 Issue: Volume:63 Page:102179
ISSN:2589-5370
Container-title:eClinicalMedicine
language:en
Short-container-title:eClinicalMedicine

Author:

Kulkarni Anand V.^ORCID,Tevethia Harshvardhan,Kumar Karan^ORCID,Premkumar Madhumita,Muttaiah Mark D.,Hiraoka Atsushi,Hatanaka Takeshi,Tada Toshifumi,Kumada Takashi,Kakizaki Satoru^ORCID,Vogel Arndt^ORCID,Finn Richard S.,Rao Padaki Nagaraja,Pillai Anjana,Reddy Duvvur Nageshwar,Singal Amit G.

Funder

F. Hoffmann-La Roche Ltd

Publisher

Elsevier BV

Subject

General Medicine

Reference81 articles.

1. Hepatocellular carcinoma;Llovet;Nat Rev Dis Prim,2021

2. Epidemiology of hepatocellular carcinoma;McGlynn;Hepatology,2021

3. 2019 update of Indian National Association for Study of the liver consensus on prevention, diagnosis, and management of hepatocellular carcinoma in India: the puri II recommendations;Kumar;J Clin Exp Hepatol,2020

4. Multidisciplinary management of hepatocellular carcinoma improves access to therapy and patient survival;Agarwal;J Clin Gastroenterol,2017

5. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome;Yopp;Ann Surg Oncol,2014

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Therapies for Hepatocellular Carcinoma in India;Journal of Clinical and Experimental Hepatology;2024-11

2. Real-World Outcomes of Atezolizumab with Bevacizumab Treatment in Hepatocellular Carcinoma Patients: Effectiveness, Esophagogastroduodenoscopy Utilization and Bleeding Complications;Cancers;2024-08-19

3. Adjuvant therapy in hepatocellular carcinoma: the IMbrave050 trial;The Lancet;2024-08

4. RECIST 1.1, mRECIST, and Choi criteria for evaluating treatment response and survival outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab;European Radiology;2024-07-30

5. Outcomes and safety of atezolizumab plus bevacizumab in the treatment of hepatocellular carcinoma: treatment prognosis and comparison with tyrosine kinase inhibitors in a French multicenter matched real-life study;European Journal of Gastroenterology & Hepatology;2024-07-26